Von Willebrand disease (VWD) type 2B, for instance, is characterized by increased interactions between VWF and platelets, resulting from gain-of-function mutations (e.g. R1306W) in the VWF A1 domain [6]. This evidence concerns the gene VWF and platelet-type von Willebrand disease.